About KN-002
KN-002 is a novel and non-invasive anti-inflammatory being developed to treat all patients with severe asthma, with potential in other respiratory diseases such as chronic obstructive pulmonary disease (COPD). KN-002 is an inhaled small molecule with improved direct delivery to the lungs to reduce systemic exposure.
